The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-Kras G12D/+ transgenic mouse model
Altaf Mohammed, Naveena B. Janakiram, Qian Li, Venkateshwar Madka, Misty Ely, Stan Lightfoot, Howard Crawford, Vernon E. Steele, Chinthalapally V. Rao
Research output: Contribution to journal › Article › peer-review
50Scopus
citations
Fingerprint
Dive into the research topics of 'The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-Kras G12D/+ transgenic mouse model'. Together they form a unique fingerprint.